Ownership history in Vivo Capital, LLC · 32 quarters on record
This page tracks every 13F SEC filing in which Vivo Capital, LLC reported a position in Verona Pharma Plc (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 1,393,432 | — | 0% | 11.97% | $148.7M | — |
| 2025 Q2 | REDUCED | 1,393,432 | -45,353 | -3.2% | 13.49% | $131.8M | — |
| 2025 Q1 | REDUCED | 1,438,785 | -845,190 | -37.0% | 12.10% | $91.3M | — |
| 2024 Q4 | REDUCED | 2,283,975 | -1,265,783 | -35.7% | 11.88% | $106.1M | — |
As of 2025 Q3 — sorted by position size